Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Sclerotherapy in children].

M Schadeck

    Phlebologie
    |November 1, 1992
    PubMed
    Summary
    This summary is machine-generated.

    Superficial venous pathology in children, often overlooked, may benefit from early intervention. Sclerotherapy shows promise as a safe and effective treatment, though medical staff acceptance remains a challenge.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Phlebology training curriculum. A consensus document of the International Union of Phlebology (UIP)-2010.

    International angiology : a journal of the International Union of Angiology·2010
    Same author

    Side-effects and complications of foam sclerotherapy of the great and small saphenous veins: a controlled multicentre prospective study including 1,025 patients.

    Phlebology·2009
    Same author

    Comparison of 1% and 3% polidocanol foam in ultrasound guided sclerotherapy of the great saphenous vein: a randomised, double-blind trial with 2 year-follow-up. "The 3/1 Study".

    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2007
    Same author

    [Current status of sclerotherapy of varicose veins].

    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2003
    Same author

    [Echographic sclerotherapy of the great saphenous vein].

    Phlebologie·1993
    Same author

    [Reflux in healthy valves of the great saphenous vein].

    Phlebologie·1991
    Same journal

    [Effect of veinotonyl 75 on the capillary permeability test using technetium albumin in cyclic orthostatic edemas].

    Phlebologie·1993
    Same journal

    [Variceal thromboses, their ambulatory treatment].

    Phlebologie·1993
    Same journal

    [Endoscopic treatment of perforating veins--current data].

    Phlebologie·1993
    Same journal

    [Program for the development and storing of images].

    Phlebologie·1993
    Same journal

    [Neutrophil activation in experimental venous hypertension].

    Phlebologie·1993
    Same journal

    [Is duplex echography mandatory in cases of deep venous insufficiency?].

    Phlebologie·1993
    See all related articles

    Area of Science:

    • Pediatric vascular medicine
    • Interventional cardiology
    • Phlebology

    Context:

    • Superficial venous pathology in children is underdiagnosed and undertreated.
    • Delayed treatment can complicate future therapeutic options.
    • Maternal history of varicose veins is a potential risk factor.

    Purpose:

    • To evaluate the efficacy and safety of sclerotherapy for pediatric superficial venous pathology.
    • To assess the feasibility of early intervention in childhood venous diseases.
    • To investigate the challenges in adopting sclerotherapy in pediatric care.

    Summary:

    • A preliminary study included 43 children with suspected venous anomalies.
    • Clinical examination and functional investigations identified significant reflux in some patients.

    Related Experiment Videos

  • Treatment ranged from observation to surgery, with sclerotherapy proving successful and well-tolerated.
  • Sclerotherapy demonstrated good outcomes with no complications, particularly in cases with reflux.

    • Impact:

    • Highlights the potential of sclerotherapy as a viable treatment for childhood venous disorders.
    • Emphasizes the need for earlier diagnosis and intervention to improve long-term outcomes.
    • Underscores the importance of addressing medical staff acceptance to facilitate wider adoption of sclerotherapy.